Jushi (OTCMKTS:JUSHF) versus ICU Medical (NASDAQ:ICUI) Head-To-Head Contrast

ICU Medical (NASDAQ:ICUI) and Jushi (OTCMKTS:JUSHF) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Insider & Institutional Ownership

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 21.7% of Jushi shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 23.1% of Jushi shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares ICU Medical and Jushi”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23 billion	1.75	$730,000.00	$1.18	132.61
Jushi	$262.91 million	0.32	-$68.59 million	($0.34)	-1.22

ICU Medical has higher revenue and earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares ICU Medical and Jushi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
Jushi	-24.44%	N/A	-15.46%

Risk and Volatility

ICU Medical has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Jushi has a beta of -0.63, meaning that its share price is 163% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for ICU Medical and Jushi, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0	3	4	2	2.89
Jushi	0	0	1	0	3.00

ICU Medical currently has a consensus target price of $192.80, suggesting a potential upside of 23.21%. Given ICU Medical’s higher probable upside, analysts clearly believe ICU Medical is more favorable than Jushi.

Summary

ICU Medical beats Jushi on 13 of the 15 factors compared between the two stocks.

About ICU Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.